Pharmaceuticals News and Research

RSS
Sundia MediTech Company recognized as technically-advanced service enterprise in Shanghai

Sundia MediTech Company recognized as technically-advanced service enterprise in Shanghai

7 Jan 2010
Ceragenix Pharmaceuticals and BioPro Pharmaceutical enter into agreement to commercialize EpiCeram

Ceragenix Pharmaceuticals and BioPro Pharmaceutical enter into agreement to commercialize EpiCeram

7 Jan 2010
IHPM and i.e. join to form MAGNETT Health to improve employees' health

IHPM and i.e. join to form MAGNETT Health to improve employees' health

7 Jan 2010
New Sermo Event Report assesses physicians' perception of multiple sclerosis drugs

New Sermo Event Report assesses physicians' perception of multiple sclerosis drugs

7 Jan 2010
E-The Environmental Magazine: Environmental toxicity drives up autism rates

E-The Environmental Magazine: Environmental toxicity drives up autism rates

7 Jan 2010
Authors explain why health care reform initiative should include CER

Authors explain why health care reform initiative should include CER

7 Jan 2010
Drug companies still under great and growing pressure to bring more products to market

Drug companies still under great and growing pressure to bring more products to market

7 Jan 2010
Teva Pharmaceutical Industries enters into two definitive agreements with AstraZeneca

Teva Pharmaceutical Industries enters into two definitive agreements with AstraZeneca

7 Jan 2010
Scientists use NIR to predict how quickly pills dissolve in body

Scientists use NIR to predict how quickly pills dissolve in body

7 Jan 2010
Balanced diet and exercise are the only reliable ways to lose weight

Balanced diet and exercise are the only reliable ways to lose weight

7 Jan 2010
Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

7 Jan 2010
Bogus drug manufactures embrace new tactics to dupe consumers

Bogus drug manufactures embrace new tactics to dupe consumers

7 Jan 2010
Watson Laboratories files ANDA to seek FDA's approval to market Nuvigil

Watson Laboratories files ANDA to seek FDA's approval to market Nuvigil

7 Jan 2010
Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

6 Jan 2010
Eisai acquires AkaRx for approximately $255 million

Eisai acquires AkaRx for approximately $255 million

6 Jan 2010
Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

6 Jan 2010
Pfizer and Strides Arcolab announce new collaboration

Pfizer and Strides Arcolab announce new collaboration

6 Jan 2010
Ensemble Discovery initiates strategic alliance with Pfizer

Ensemble Discovery initiates strategic alliance with Pfizer

6 Jan 2010
Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

Oral cladribine to be the first oral disease-modifying multiple sclerosis therapy despite receiving RTF letter

6 Jan 2010
OncoGenex Pharmaceuticals receives grant funding for Phase 2 clinical trial of OGX-427

OncoGenex Pharmaceuticals receives grant funding for Phase 2 clinical trial of OGX-427

6 Jan 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback